From: Should patients older than 65 years be offered a second kidney transplant?
TX2 (N = 46) | TX1 (N = 687) | P-value | |
---|---|---|---|
Age (years) | 69.3 (65.1-81.6) | 71.0 (65.0-82.9) | 0.009 |
Male recipient | 28 (61%) | 492 (71.6%) | 0.132 |
Pre-emptive transplantation | 6 (13%) | 116 (16.9%) | 0.682 |
Coronary heart disease | 4 (9%) | 190 (27.7%) | 0.003 |
Diabetes mellitus | 4 (9%) | 152 (22.1%) | 0.039 |
Cerebrovascular disease | 4 (9%) | 81 (11.8%) | 0.641 |
Peripheral vascular disease | 5 (11%) | 145 (21.1%) | 0.129 |
Pre-emptive transplantation | 6 (13%) | 116 (16.9%) | 0.682 |
Hemodialysis | 34 (74%) | 446 (64.9%) | 0.263 |
Peritoneal Dialysis | 6 (13%) | 125 (18.2%) | 0.550 |
Time on dialysis (months) | 15.5 (0–108) | 18.0 (0–87) | 0.584 |
PRA positive B-cell screening | 8 (17%) | 24 (3.5%) | <0.001 |
CMV positive recipient | 43 (94%) | 568 (82.7%) | 0.065 |
CMV positive donor | 33 (72%) | 513 (74.8%) | 0.605 |
Male donor | 28 (61%) | 387 (56.3%) | 0.645 |
Donor age (years) | 64.1 (33.1-85.4) | 61.2 (1.6-89.0) | 0.106 |
Donor > 60 years | 31 (67%) | 364 (53.0%) | 0.067 |
No HLA-A mismatch | 13 (28%) | 129 (18.8%) | 0.124 |
No HLA-B mismatch | 9 (20%) | 77 (11.2%) | 0.097 |
No HLA-DR mismatch | 20 (44%) | 318 (46.3%) | 0.761 |
Cold ischemia time (h) | 13.4 (3.8-20.2) | 13.9 (2.8-29.0) | 0.104 |